These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 6415508)

  • 21. Effects of B-HT 920 on nigrostriatal and mesolimbic dopamine systems in normosensitive and supersensitive rats.
    Clarke PB; Wyder KJ; Jakubovic A; Fibiger HC
    Br J Pharmacol; 1990 Mar; 99(3):509-15. PubMed ID: 2110017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship between striatal and mesolimbic dopamine dysfunction and the nature of circling responses following 6-hydroxydopamine and electrolytic lesions of the ascending dopamine systems of rat brain.
    Costall B; Marsden CD; Naylor RJ; Pycock CJ
    Brain Res; 1976 Dec; 118(1):87-113. PubMed ID: 990957
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulatory behaviour, exploration and locomotion following NMDA or 6-OHDA lesions in the rat nucleus accumbens.
    Weissenborn R; Winn P
    Behav Brain Res; 1992 Nov; 51(2):127-37. PubMed ID: 1466779
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of dopamine depletion from the caudate-putamen and nucleus accumbens septi on the acquisition and performance of a conditional discrimination task.
    Robbins TW; Giardini V; Jones GH; Reading P; Sahakian BJ
    Behav Brain Res; 1990 May; 38(3):243-61. PubMed ID: 2114120
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mesolimbicocortical dopamine terminal fields are necessary for normal locomotor and investigatory exploration in rats.
    Fink JS; Smith GP
    Brain Res; 1980 Oct; 199(2):359-84. PubMed ID: 7417789
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesolimbic dopamine neurons: effects of 6-hydroxydopamine-induced destruction and receptor blockade on drug-induced rotation of rats.
    Kelly PH; Moore KE
    Psychopharmacology (Berl); 1977 Nov; 55(1):35-41. PubMed ID: 414259
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Transmitter release from transplants of fetal ventral mesencephalon or locus coeruleus in the rat frontal cortex and nucleus accumbens: effects of pharmacological and behaviorally activating stimuli.
    Cenci MA; Kalén P; Duan WM; Björklund A
    Brain Res; 1994 Apr; 641(2):225-48. PubMed ID: 8012825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic substrates of amphetamine-induced place preference conditioning.
    Spyraki C; Fibiger HC; Phillips AG
    Brain Res; 1982 Dec; 253(1-2):185-93. PubMed ID: 6817850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuroleptic-like disruption of the conditioned avoidance response requires destruction of both the mesolimbic and nigrostriatal dopamine systems.
    Koob GF; Simon H; Herman JP; Le Moal M
    Brain Res; 1984 Jun; 303(2):319-29. PubMed ID: 6430466
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional recovery after destruction of dopamine systems in the nucleus accumbens of rats. I. Behavioral and biochemical studies.
    Wolterink G; Van Zanten E; Kamsteeg H; Radhakishun FS; Van Ree JM
    Brain Res; 1990 Jan; 507(1):92-100. PubMed ID: 2105824
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phencyclidine binding sites in the nucleus accumbens and phencyclidine-induced hyperactivity are decreased following lesions of the mesolimbic dopamine system.
    French ED; Pilapil C; Quirion R
    Eur J Pharmacol; 1985 Oct; 116(1-2):1-9. PubMed ID: 2996909
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Locomotor activity in relation to dopamine and noradrenaline in the nucleus accumbens, septal and frontal areas: a 6-hydroxydopamine study.
    Oades RD; Taghzouti K; Rivet JM; Simon H; Le Moal M
    Neuropsychobiology; 1986; 16(1):37-42. PubMed ID: 3106851
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injections of 6-hydroxydopamine in the substantia nigra of the rat brain: morphological and biochemical effects.
    Buonamici M; Cervini MA; Rossi AC; Sebastiani L; Raffaelli A; Bagnoli P
    Behav Brain Res; 1990 Apr; 38(1):83-95. PubMed ID: 2112003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Abnormal pattern of amphetamine locomotion after 6-OHDA lesion of anteromedial caudate.
    Fink JS; Smith GP
    Pharmacol Biochem Behav; 1979 Jul; 11(1):23-30. PubMed ID: 493296
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of mesolimbic dopamine in conditioned locomotion produced by amphetamine.
    Gold LH; Swerdlow NR; Koob GF
    Behav Neurosci; 1988 Aug; 102(4):544-52. PubMed ID: 3139012
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Electrolytic lesions of the substantia innominata and lateral preoptic area attenuate the 'supersensitive' locomotor response to apomorphine resulting from denervation of the nucleus accumbens.
    Swerdlow NR; Swanson LW; Koob GF
    Brain Res; 1984 Jul; 306(1-2):141-8. PubMed ID: 6087974
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dopamine agonist-induced locomotor activity in rats treated with 6-hydroxydopamine at differing ages: functional supersensitivity of D-1 dopamine receptors in neonatally lesioned rats.
    Breese GR; Napier TC; Mueller RA
    J Pharmacol Exp Ther; 1985 Aug; 234(2):447-55. PubMed ID: 3926987
    [TBL] [Abstract][Full Text] [Related]  

  • 38. 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine.
    Taylor JR; Robbins TW
    Psychopharmacology (Berl); 1986; 90(3):390-7. PubMed ID: 3097729
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Differential effects of mesocortical, mesolimbic, and mesostriatal dopamine depletion on spontaneous, conditioned, and drug-induced locomotor activity.
    Jones GH; Robbins TW
    Pharmacol Biochem Behav; 1992 Nov; 43(3):887-95. PubMed ID: 1448483
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dopamine-rich transplants in rats with 6-OHDA lesions of the ventral tegmental area. I. Effects on spontaneous and drug-induced locomotor activity.
    Dunnett SB; Bunch ST; Gage FH; Björklund A
    Behav Brain Res; 1984 Jul; 13(1):71-82. PubMed ID: 6477720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.